Log in
Products
Latest News
FAQ
Log in
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
Newest First
Treatment of Cancer with Immune Checkpoint Inhibition Therapy Boosted by High Intensity Focused Ultrasound Histotripsy
Phase 1
Active, not recruiting
Conditions
Cancer
Metastatic Cancer
Interventions
Device: HIFU-HT
Drug: ICI
Subscribe
First Posted Date
2024-07-29
Last Posted Date
2025-01-07
Lead Sponsor
UMC Utrecht
Target Recruit Count
24
Registration Number
NCT06524570
Locations
🇳🇱
University Medical Center Utrecht, Utrecht, Netherlands
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy